MedTrace Logo

LGG/BB12-pastille Study

NCT01577485 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2013-01-04

No results posted yet for this study

Summary

We want to study the effect of short-term consumption of probiotics (a mixture of L. rhamnosus GG and B. lactis BB-12)on the composition of the oral flora.

Conditions

  • Probiotics

Interventions

DIETARY_SUPPLEMENT

Probiotics in an pastille

Test group

DIETARY_SUPPLEMENT

Control pastille

Control group

Sponsors & Collaborators

  • University of Michigan

    collaborator OTHER

  • The Forsyth Institute

    collaborator OTHER

  • University of Turku

    lead OTHER

Principal Investigators

  • Eva M Söderling · Associate Professor

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2012-11-30
Completion
2012-11-30

Countries

  • Finland

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01577485 on ClinicalTrials.gov